Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Teva Pharmaceuticals USA

Teva Pharmaceuticals USA Recalls

All product recalls associated with Teva Pharmaceuticals USA.

Get alerts for this brand

Recall Summary

Total Recalls

265

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 201–220 of 265 recalls

Dextroamphetamine Amphetamine (Teva) – Impurity Concern (2014)

Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.

Class IIModerate

FDAOct 8, 2014Nationwide• Teva Pharmaceuticals USA

Velivet (Teva) – Impurity Specification Failure (2014)

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Class IIILow

FDAJun 17, 2014Nationwide• Teva Pharmaceuticals USA

Kariva (Teva) – Impurity Specification Failure (2014)

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Class III

1...9 101112 13 14

Page 11 of 14Next

Low

FDAJun 17, 2014Nationwide• Teva Pharmaceuticals USA

Apri (Teva) – Impurity Specification Failure (2014)

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Class IIILow

FDAJun 17, 2014Nationwide• Teva Pharmaceuticals USA

Mircette (Teva) – Impurity Specification Failure (2014)

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Class IIILow

FDAJun 17, 2014Nationwide• Teva Pharmaceuticals USA

Carbidopa Levodopa (Teva) – Tablet Specification (2014)

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

Class IIModerate

FDAJun 5, 2014Nationwide• Teva Pharmaceuticals USA

Fluvastatin Capsules (Teva) – failed specifications (2014)

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.

Class IIModerate

FDAMay 29, 2014Nationwide• Teva Pharmaceuticals USA

Dextroamphetamine Tablets (Teva) – Impurity Specifications (2014)

Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

Class IIModerate

FDAMay 1, 2014Nationwide• Teva Pharmaceuticals USA

QVAR Inhalation Aerosol (Teva) – Defective Valve (2014)

Defective Delivery System; defective valve

Class IIModerate

FDAApr 23, 2014Nationwide• Teva Pharmaceuticals USA

Buprenorphine Sublingual Tablets (Teva) – impurity issue (2014)

Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.

Class IIModerate

FDAApr 7, 2014Nationwide• Teva Pharmaceuticals USA

Buprenorphine Sublingual Tablets (Teva) – impurity problem (2014)

Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.

Class IIModerate

FDAApr 7, 2014Nationwide• Teva Pharmaceuticals USA

Lansoprazole Triple Therapy (Teva) – impurity concern (2014)

Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.

Class IIModerate

FDAApr 1, 2014Nationwide• Teva Pharmaceuticals USA

Indomethacin Capsules (Teva) – Manufacturing Deviation (2014)

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.

Class IIModerate

FDAMar 24, 2014Nationwide• Teva Pharmaceuticals USA

Methyldopa Tablets (Teva) – Manufacturing Deviation (2014)

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

Class IIModerate

FDAMar 24, 2014Nationwide• Teva Pharmaceuticals USA

Glyburide Metformin Tablets 5/500mg (Teva) – Manufacturing Deviation (2014)

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

Class IIModerate

FDAMar 24, 2014Nationwide• Teva Pharmaceuticals USA

Indomethacin Capsules 25mg (Teva) – Manufacturing Deviation (2014)

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

Class IIModerate

FDAMar 24, 2014Nationwide• Teva Pharmaceuticals USA

ParaGard T 380A Copper IUD (Teva) – Non-Sterile Device (2014)

Non-sterility: due to a failed sterility test

Class IIModerate

FDAMar 21, 2014KY, NY• Teva Pharmaceuticals USA

Duloxetine Capsules (Teva) – specification failure (2014)

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA

Duloxetine Capsules (Teva) – specification failure (2014)

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA

Duloxetine Capsules (Teva) – specification failure (2014)

Class IIModerate

FDAMar 4, 2014Nationwide• Teva Pharmaceuticals USA